ALKS
Alkermes PlcNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$7.38B
P/E Ratio
49.20
EPS
$0.90
Beta
0.33
52W High
$45.76
52W Low
$25.17
50-Day MA
$37.02
200-Day MA
$31.87
Dividend Yield
—
Profit Margin
9.77%
Forward P/E
116.28
PEG Ratio
1.96
About Alkermes Plc
Alkermes plc, a biopharmaceutical company, researches, develops and markets pharmaceutical products to address the unmet medical needs of patients in various therapeutic areas in the United States, Ireland and internationally. The company is headquartered in Dublin, Ireland.
Fundamentals
| Revenue (TTM) | $1.56B |
| Gross Profit (TTM) | $1.37B |
| EBITDA | $278.58M |
| Operating Margin | -0.19% |
| Return on Equity | 9.36% |
| Return on Assets | 4.72% |
| Revenue/Share (TTM) | $9.45 |
| Book Value | $10.52 |
| Price-to-Book | 4.21 |
| Price-to-Sales (TTM) | 4.72 |
| EV/Revenue | 5.41 |
| EV/EBITDA | 30.57 |
| Quarterly Earnings Growth (YoY) | -67.00% |
| Quarterly Revenue Growth (YoY) | 28.20% |
| Shares Outstanding | $166.68M |
| Float | $154.07M |
| % Insiders | 1.43% |
| % Institutions | 110.36% |
Historical Volatility
HV 10-Day
35.96%
HV 20-Day
37.00%
HV 30-Day
42.03%
HV 60-Day
49.99%
HV Rank
75.4%
Volatility is currently contracting
Analyst Ratings
Consensus ($46.12 target)
3
Strong Buy11
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026